Dr. Celine Gounder joins CBS Mornings to break down the FDA-approved drug Lenacapavir, which is being called the closest step yet to an HIV vaccine.
BreakdownGenerated by LeadStory AI
- Lenacapavir, a twice-yearly HIV prevention injection, has been approved by the FDA. 3s
- The drug has shown nearly 100% efficacy in preventing HIV in clinical trials. 19s
- Lenacapavir improves convenience and adherence compared to daily pills, benefiting underserved groups such as women and people of color. 41s
- Clinical trials included pregnant and breastfeeding women, allowing immediate access for these groups. 2m 2s
- The drug's high cost and recent cuts to CDC HIV prevention funding may impact access and rollout. 2m 30s